Page last updated: 2024-12-07

ly 243670

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

LY 243670: Ly 243670 is a mixture of four isomers having a trans-3,4-dimethyl configuration; structure of LY 255582 given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129316
SCHEMBL ID8415197
MeSH IDM0192497

Synonyms (22)

Synonym
ly 243670
3-[1-(3-cyclohexyl-3-hydroxypropyl)-3,4-dimethylpiperidin-4-yl]phenol
1-(3-hydroxy-3-cyclohexylpropyl)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidine
ly255610
ly-255609
ly255265
ly 255609
ly-243670
120938-72-9
1-piperidinepropanol, alpha-cyclohexyl-4-(3-hydroxyphenyl)-3,4-dimethyl-
ly 255265
ly255609
ly-255265
ly243670
ly 255610
ly-255610
SCHEMBL8415197
DTXSID10923610
3-[1-[(s)-3-hydroxy-3-cyclohexylpropyl]-3alpha,4-dimethylpiperidine-4alpha-yl]phenol
PD093305
AKOS040752773
1-piperidinepropanol, alpha-cyclohexyl-4-(3-hydroxyphenyl)-3,4-dimethy l-

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of parent LY255582 was < 1% in both the rat and the dog, primarily because of extensive first-pass metabolism."( Disposition of the opioid antagonist, LY255582, in rats and dogs.
Catlow, J; Chay, SH; Johnson, T; Pohland, RC; Swanson, SP, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (38.46)18.2507
2000's6 (46.15)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.65 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]